Hildred to take majority stake in Crown Laboratories

Hildred Capital Partners LLC has agreed to acquire a major stake in Tennessee-based Crown Laboratories Inc, a specialty pharmaceutical company. No financial terms were disclosed. The deal is expected to close in the fourth quarter of 2017. Lowenstein Sandler LLP was legal adviser to Hildred while Torreya Partners LLC and Michael Best & Friedrich LLP acted as financial and legal advisers, respectively, to Crown Laboratories.

30 October 2017•4 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles